Clinical Trial Update: Patient Reported Outcomes in Friedreich's Ataxia Patients After Withdrawal From Treatment With Idebenone (PROTI) [Phase 3]

View source ↗

Summary

This Phase 3 trial update summarizes patient-reported outcomes in Friedreich's Ataxia patients after withdrawal from idebenone treatment. The trial results were…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Friedreich Ataxia

Drugs mentioned

• Idebenone (idebenone)

Snippet

Sponsor: Santhera Pharmaceuticals | Conditions: Friedreich's Ataxia | Phase 3 | Status: COMPLETED | Results posted: 2016-03-09